Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil

Cancer Chemother Pharmacol. 2002 May;49(5):398-402. doi: 10.1007/s00280-002-0431-9. Epub 2002 Feb 23.

Abstract

Aims: To determine the effect of food on the pharmacokinetics of 5-fluoruracil (5-FU) taken orally with eniluracil and to compare the performance of different pharmacokinetic analysis methods in the detection a potential food-drug interaction.

Methods: In a randomized, open-label, two-way crossover study, 12 patients received eniluracil (50 mg, orally) on days 1 and 2 and 5-FU (20 mg/m(2), orally) on day 2 following either a 2-h fast or 20 min after a standard meal. Treatments were separated by 7 days. Timed blood samples were collected during the first two treatment periods and 5-FU concentrations determined by GC/MS. Data were analyzed and pharmacokinetic parameter estimates were obtained using a noncompartmental, two-stage and population analysis methods.

Results: In fasted individuals, the clearance/bioavailability of 5-FU was estimated to be 5.6 l/h. The mean absorption lag-time was 0.24 h and was followed by rapid absorption of 5-FU. Administration of 5-FU and eniluracil with food resulted in a decrease in the 5-FU absorption rate constant by 90%. As a result, the peak plasma concentration (C(max)) of 5-FU was decreased by 21% and the time to C(max) was increased 2.9-fold. Clearance of 5-FU, relative bioavailability, and area under the plasma concentration vs time curve (AUC) remained unchanged with coadministration of food. Similar results were obtained using all three data analysis methods.

Conclusions: Administration of food with oral 5-FU and eniluracil slowed absorption of 5-FU and decreased 5-FU C(max), but did not effect AUC. Further investigation of the incorporation of population pharmacokinetic approaches in food effect studies is warranted.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Antineoplastic Agents / pharmacokinetics*
  • Area Under Curve
  • Cross-Over Studies
  • Dihydrouracil Dehydrogenase (NADP)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Fluorouracil / pharmacokinetics*
  • Food-Drug Interactions / physiology*
  • Humans
  • Intestinal Absorption
  • Male
  • Middle Aged
  • Models, Biological
  • Oxidoreductases / antagonists & inhibitors
  • Population
  • Therapeutic Equivalency
  • Uracil / analogs & derivatives*
  • Uracil / pharmacology*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • eniluracil
  • Uracil
  • Oxidoreductases
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil